VEGFA and neoplasm: Recent evidence of the strong predictive value of VEGF in premenopausal early breast cancer patients [58], as well as the predictive significance of tumor angiogenesis in high-risk early breast cancer patients [59], underlines the need for additional studies that could possibly support and/or clarify these findings.